What is Tenaya Therapeutics, Inc. Common Stock's Market Cap?

Tenaya Therapeutics, Inc. Common Stock's Market Cap is $148.8M, based on as-reported figures from SEC (XBRL) filings.

What is Tenaya Therapeutics, Inc. Common Stock's Enterprise Value?

Tenaya Therapeutics, Inc. Common Stock's Enterprise Value is $70.7M, based on as-reported figures from SEC (XBRL) filings.

What is Tenaya Therapeutics, Inc. Common Stock's EV / EBITDA?

Tenaya Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Tenaya Therapeutics, Inc. Common Stock's Net Income (TTM)?

Tenaya Therapeutics, Inc. Common Stock's Net Income (TTM) is -$103.1M, based on as-reported figures from SEC (XBRL) filings.

What is Tenaya Therapeutics, Inc. Common Stock's EBITDA?

Tenaya Therapeutics, Inc. Common Stock's EBITDA is -$98.7M, based on as-reported figures from SEC (XBRL) filings.

What is Tenaya Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Tenaya Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.46, based on as-reported figures from SEC (XBRL) filings.

What is Tenaya Therapeutics, Inc. Common Stock's Net Debt?

Tenaya Therapeutics, Inc. Common Stock's Net Debt is -$78.1M, based on as-reported figures from SEC (XBRL) filings.

Tenaya Therapeutics, Inc. Common Stock (TNYA) Financial Statements

Tenaya Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00FPMK2T2

XNAS · usd

0.66▼ 0.02 (-2.90%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.68

Day's Range0.66 – 0.71

52-Week Range0.53 – 2.35

Volume2.3M

Avg Volume1.9M

Share Statistics

Shares Outstanding

Employees70

ExchangeXNAS

Listed2021-07-30

Share count as of July 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Tenaya Therapeutics, Inc. Common Stock (TNYA)

What is Tenaya Therapeutics, Inc. Common Stock's Market Cap?: Tenaya Therapeutics, Inc. Common Stock's Market Cap is $148.8M, based on as-reported figures from SEC (XBRL) filings.
What is Tenaya Therapeutics, Inc. Common Stock's Enterprise Value?: Tenaya Therapeutics, Inc. Common Stock's Enterprise Value is $70.7M, based on as-reported figures from SEC (XBRL) filings.
What is Tenaya Therapeutics, Inc. Common Stock's EV / EBITDA?: Tenaya Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Tenaya Therapeutics, Inc. Common Stock's Net Income (TTM)?: Tenaya Therapeutics, Inc. Common Stock's Net Income (TTM) is -$103.1M, based on as-reported figures from SEC (XBRL) filings.
What is Tenaya Therapeutics, Inc. Common Stock's EBITDA?: Tenaya Therapeutics, Inc. Common Stock's EBITDA is -$98.7M, based on as-reported figures from SEC (XBRL) filings.
What is Tenaya Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Tenaya Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.46, based on as-reported figures from SEC (XBRL) filings.
What is Tenaya Therapeutics, Inc. Common Stock's Net Debt?: Tenaya Therapeutics, Inc. Common Stock's Net Debt is -$78.1M, based on as-reported figures from SEC (XBRL) filings.